Search
01/09/2024
Improvement in lung function after six months of treatment with extrafine formulation single-inhaler triple therapy (efSITT) in patients with asthma-TriMaximize Study
Gessner, C, Bogoevska, V, Nachtigall, D, Russell, R, Ulrik, CS, Pohl, W, Plaza, V, Bourdin, A, Criée, CP, Trinkmann, F. Improvement in lung function after six months of treatment with extrafine formulation single-inhaler triple therapy (efSITT) in patients with asthma-TriMaximize Study. EUROPEAN RESPIRATORY JOURNAL. 2024; 64DOI:10.1183/13993003.congress-2024.PA2121. PMID:. IF:21.000(Q1/1D).
01/09/2024
Impact of extrafine formulation single-inhaler triple therapy on asthma control and treatment adherence after six months of treatment in patients with asthma-TriMaximize study
Greulich, T, Bogoevska, V, Nachtigall, D, Russell, R, Suppli, C, Wolfgang, U, Pohl, W, Plaza, V, Bourdin, A, Baumeister, S, Gessner, C. Impact of extrafine formulation single-inhaler triple therapy on asthma control and treatment adherence after six months of treatment in patients with asthma-TriMaximize study. EUROPEAN RESPIRATORY JOURNAL. 2024; 64DOI:10.1183/13993003.congress-2024.PA3907. PMID:. IF:21.000(Q1/1D).
01/08/2024
Spanish Consensus on Remission in Asthma (REMAS)
Alvarez-Gutiérrez, FJ, Casas-Maldonado, F, Soto-Campos, G, Blanco-Aparicio, M, Delgado, J, Galo, AP, Quirce, S, Plaza, V. Spanish Consensus on Remission in Asthma (REMAS). ARCHIVOS DE BRONCONEUMOLOGIA. 2024; 60(8)DOI:10.1016/j.arbres.2024.04.002. PMID:38697903. IF:9.200(Q1/1D).
01/06/2024
Diagnostic Value of Krebs von den Lungen (KL-6) for Interstitial Lung Disease: A European Prospective Cohort
Millan-Billi, P, Castellví, I, Martinez-Martinez, L, Mariscal, A, Barril, S, D'Alessandro, M, Franquet, T, Castillo, D. Diagnostic Value of Krebs von den Lungen (KL-6) for Interstitial Lung Disease: A European Prospective Cohort. ARCHIVOS DE BRONCONEUMOLOGIA. 2024; 60(6)DOI:10.1016/j.arbres.2024.03.028. PMID:38644152. IF:9.200(Q1/1D).